Square Pharma revenue jumps 15% to Tk4,338cr in H1
Square Pharmaceuticals PLC, the country's leading drug maker, posted strong growth in both revenue and profit in the first half of the current fiscal year, reflecting steady domestic demand and continued expansion of its overseas operations.
According to the company's financial disclosure, consolidated revenue rose by 15% year-on-year to Tk4,338 crore in the July-December period, compared to Tk3,771 crore in the same period a year earlier. Consolidated net profit increased by 16% to Tk1,467 crore during the half-year, while earnings per share stood at Tk16.56.
In the second quarter alone, covering October to December, Square Pharma reported a 9% increase in consolidated revenue to Tk2,179 crore. Net profit for the quarter surged by 10% to Tk727 crore, indicating sustained momentum despite rising costs faced by the broader pharmaceutical sector.
Keep updated, follow The Business Standard's Google news channel
The consolidated results include contributions from Square Pharmaceuticals Kenya EPZ Ltd, its foreign subsidiary, local subsidiary Square Lifesciences Ltd, and three associate companies – Square Textiles, Square Fashions and Square Hospitals – highlighting the diversified nature of the group's operations.
Square Pharma has also continued its strong shareholder return policy. Earlier, the company declared a 120% cash dividend for FY25, equivalent to Tk12 per share, marking the highest payout in its corporate history. In the previous fiscal year, it had distributed a 110% cash dividend, reinforcing its track record of consistent and rising payouts.
The company, listed on the stock exchanges since 1995, saw its shares close at Tk218.90 on Thursday. With a market capitalisation of around Tk19,400 crore, Square Pharma currently ranks as the second-largest listed company on the Dhaka Stock Exchange.
Founded in 1958 by the late Samson H Chowdhury, Square Pharmaceuticals began operations at a time when Bangladesh's pharmaceutical market was largely dominated by multinational companies. Over the decades, it has grown into a market leader, producing around 1,000 varieties of medicines. Its flagship gastric relief brand Seclo remains one of the top-selling products in the country.
Square Pharma was also the first Bangladeshi pharmaceutical company to export medicines overseas in 1987. At present, it exports pharmaceutical products to 42 countries across Asia, Africa and Latin America, strengthening its position as a regional healthcare player.
